Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ando, Katsuyuki"" wg kryterium: Autor


Tytuł :
Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.
Autorzy :
Ando K; Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo.
Shimada K; Department of Cardiology, Shin-Oyama City Hospital, Tochigi.
Yamazaki T; Department of Cardiology, Shin-Oyama City Hospital, Tochigi.
Uchiyama S; International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center.
Uemura Y; Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital.
Ishizuka N; Clinical Trial Department, Cancer Institute Hospital.
Teramoto T; Teikyo Academic Research Center, Teikyo University.
Oikawa S; Diabetes and Lifestyle Disease Center, Fukujyuji Hospital.
Sugawara M; Department of Internal Medicine, Sugawara Medical Clinic, Japan Physician's Association.
Murata M; Clinical Laboratory, Keio University School of Medicine.
Yokoyama K; Department of Hematology/Oncology, Tokai University Hachioji Hospital.
Ikeda Y; Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
Japanese Primary Prevention Project (JPPP) Study Group
Źródło :
Journal of hypertension [J Hypertens] 2019 Jun; Vol. 37 (6), pp. 1301-1307.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Aspirin/*therapeutic use
Hypertension/*complications
Myocardial Infarction/*prevention & control
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*prevention & control
Aged ; Aged, 80 and over ; Blood Pressure ; Diabetes Mellitus ; Dyslipidemias/complications ; Female ; Hemorrhage/chemically induced ; Humans ; Intracranial Hemorrhages/chemically induced ; Male ; Middle Aged ; Primary Prevention ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
Autorzy :
Uchiyama S; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.). .
Ishizuka N; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Shimada K; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Teramoto T; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Yamazaki T; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Oikawa S; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Sugawara M; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Ando K; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Murata M; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Yokoyama K; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Minematsu K; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Matsumoto M; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Ikeda Y; From the Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan (S.U.); Clinical Trial Department, Cancer Institute Hospital, Tokyo, Japan (N.I.); Department of Cardiology, Shin-Oyama City Hospital, Tochigi, Japan (K.S.); Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (T.T.); Clinical Research Support Center, Center for Epidemiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan (T.Y.); Diabetes and Life Style Disease Center, Fukujyuji Hospital, Tokyo, Japan (S.O.); Japan Physician's Association, Tokyo, Japan (M.S.); Department of Internal Medicine, Kitamura Memorial Clinic, Tokyo, Japan (K.A.); Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan (M. Murata); Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan (K.Y.); National Cerebral and Cardiovascular Center, Osaka, Japan (K.M.); Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Hiroshima, Japan (M. Matsumoto); and Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (Y.I.).
Pokaż więcej
Corporate Authors :
JPPP Study Group
Źródło :
Stroke [Stroke] 2016 Jun; Vol. 47 (6), pp. 1605-11. Date of Electronic Publication: 2016 May 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Diabetes Mellitus*/epidemiology
Dyslipidemias*/epidemiology
Hypertension*/epidemiology
Aspirin/*therapeutic use
Brain Ischemia/*prevention & control
Intracranial Hemorrhages/*epidemiology
Outcome Assessment, Health Care/*statistics & numerical data
Platelet Aggregation Inhibitors/*therapeutic use
Primary Prevention/*statistics & numerical data
Stroke/*prevention & control
Aged ; Aged, 80 and over ; Aspirin/adverse effects ; Brain Ischemia/epidemiology ; Comorbidity ; Female ; Follow-Up Studies ; Humans ; Intracranial Hemorrhages/chemically induced ; Japan/epidemiology ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Risk Factors ; Stroke/epidemiology
Czasopismo naukowe
Tytuł :
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial.
Autorzy :
Ando K; The University of Tokyo, Tokyo, Japan.
Ohtsu H
Uchida S
Kaname S
Arakawa Y
Fujita T
Pokaż więcej
Corporate Authors :
EVALUATE Study Group
Źródło :
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2014 Dec; Vol. 2 (12), pp. 944-53.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Albuminuria/*drug therapy
Hypertension/*drug therapy
Mineralocorticoid Receptor Antagonists/*therapeutic use
Protective Agents/*therapeutic use
Spironolactone/*analogs & derivatives
Adult ; Aged ; Antihypertensive Agents/pharmacology ; Creatinine/urine ; Double-Blind Method ; Eplerenone ; Female ; Humans ; Male ; Middle Aged ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/drug therapy ; Spironolactone/therapeutic use
Czasopismo naukowe
Tytuł :
Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study.
Autorzy :
Ando K; 1. Division of Molecular Cardiovascular Metabolism, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Nitta K; 2. Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Rakugi H; 3. Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Nishizawa Y; 4. Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yokoyama H; 5. Division of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan.
Nakanishi T; 6. Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.
Kashihara N; 7. Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
Tomita K; 8. Department of Nephrology, Graduate School of Faculty of Life Science, Kumamoto University, Kumamoto, Japan.
Nangaku M; 9. Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Takahashi K; 9. Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Isshiki M; 9. Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Shimosawa T; 10. Department of Clinical Laboratory, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Fujita T; 11. Division of Clinical Epigenetics, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
International journal of medical sciences [Int J Med Sci] 2014 Jun 21; Vol. 11 (9), pp. 897-904. Date of Electronic Publication: 2014 Jun 21 (Print Publication: 2014).
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Dihydropyridines/*administration & dosage
Hydrochlorothiazide/*administration & dosage
Hypertension/*drug therapy
Renal Insufficiency, Chronic/*drug therapy
Adult ; Aged ; Albuminuria/chemically induced ; Albuminuria/pathology ; Amlodipine/therapeutic use ; Blood Pressure/drug effects ; Female ; Glomerular Filtration Rate/drug effects ; Humans ; Hypertension/complications ; Hypertension/pathology ; Male ; Middle Aged ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/pathology ; Renin-Angiotensin System/drug effects
Czasopismo naukowe
Tytuł :
[Scientific statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension (3) Assessment and application of salt intake in the management of hypertension.
Autorzy :
Tsuchihashi T; Division of Hypertension, National Kyushu Medical Center, Clinical Research Institute, Fukuoka, Japan.
Kai H
Kusaka M
Kawamura M
Matsuura H
Miura K
Ando K
Maruyama S
Hayabuchi H
Takagi Y
Nakahigashi N
Sato T
Kawano Y
Pokaż więcej
Źródło :
Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2013 Dec; Vol. 36 (12), pp. 1026-31. Date of Electronic Publication: 2013 Oct 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diet, Sodium-Restricted*
Hypertension/*diet therapy
Sodium Chloride, Dietary/*analysis
Creatinine/urine ; Diet ; Diet Records ; Humans ; Japan ; Nutrition Surveys ; Societies, Medical ; Sodium/urine ; Sodium Chloride, Dietary/adverse effects ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
[Scientific statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension(2) Goal and strategies of dietary salt reduction in the management of hypertension.
Autorzy :
Miura K; Department of Health Science, Shiga University of Medical Science, Otsu, Japan.
Ando K
Tsuchihashi T
Yoshita K
Watanabe Y
Kawarazaki H
Matsuura H
Kusaka M
Kai H
Kawamura M
Kawano Y
Pokaż więcej
Źródło :
Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2013 Dec; Vol. 36 (12), pp. 1020-5. Date of Electronic Publication: 2013 Oct 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diet, Sodium-Restricted*
Hypertension/*diet therapy
Sodium Chloride, Dietary/*analysis
Adult ; Diet Surveys ; Female ; Goals ; Humans ; Japan/epidemiology ; Male ; Population ; Societies, Medical
Czasopismo naukowe
Tytuł :
[Scientific statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension(1) Role of salt in hypertension and cardiovascular diseases.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Kawarazaki H
Miura K
Matsuura H
Watanabe Y
Yoshita K
Kawamura M
Kusaka M
Kai H
Tsuchihashi T
Kawano Y
Pokaż więcej
Źródło :
Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2013 Dec; Vol. 36 (12), pp. 1009-19. Date of Electronic Publication: 2013 Oct 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diet, Sodium-Restricted*
Cardiovascular Diseases/*etiology
Hypertension/*etiology
Sodium, Dietary/*adverse effects
Blood Pressure/drug effects ; Cardiovascular Diseases/mortality ; Diet ; Exercise ; Feeding Behavior ; Humans ; Hypertension/mortality ; Japan/epidemiology ; Kidney/metabolism ; Life Style ; Societies, Medical ; Sodium/urine ; Stress, Physiological
Czasopismo naukowe
Tytuł :
L-/N-type calcium channel blockers and proteinuria.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, 7-3- 1 Hongo, Bunkkyo-ku, Tokyo, 113-8655, Japan. .
Pokaż więcej
Źródło :
Current hypertension reviews [Curr Hypertens Rev] 2013 Aug; Vol. 9 (3), pp. 210-8.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Evidence-Based Medicine*
Calcium Channel Blockers/*therapeutic use
Calcium Channels, L-Type/*drug effects
Calcium Channels, N-Type/*drug effects
Hypertension/*drug therapy
Proteinuria/*drug therapy
Albuminuria/drug therapy ; Blood Pressure/drug effects ; Calcium Channel Blockers/pharmacology ; Humans ; Kidney/drug effects ; Renin-Angiotensin System/drug effects
Czasopismo naukowe
Tytuł :
Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
Autorzy :
Kawarazaki H; Department of Nephrology and Hypertension, St. Marianna University School of Medicine, Kanagawa, Japan. />Ando K
Shibata S
Muraoka K
Fujita M
Kawarasaki C
Fujita T
Pokaż więcej
Źródło :
Journal of hypertension [J Hypertens] 2012 Oct; Vol. 30 (10), pp. 1977-85.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Oxidative Stress*
Sexual Maturation*
Hypertension/*physiopathology
Kidney Diseases/*physiopathology
Receptors, Mineralocorticoid/*physiology
Sodium Chloride, Dietary/*adverse effects
rac1 GTP-Binding Protein/*metabolism
Animals ; Blotting, Western ; Hypertension/etiology ; Kidney Diseases/etiology ; Male ; Nephrectomy ; Rats ; Rats, Sprague-Dawley ; Real-Time Polymerase Chain Reaction ; Receptors, Mineralocorticoid/drug effects ; Reverse Transcriptase Polymerase Chain Reaction
Czasopismo naukowe
Tytuł :
Pathophysiology of salt sensitivity hypertension.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Fujita T
Pokaż więcej
Źródło :
Annals of medicine [Ann Med] 2012 Jun; Vol. 44 Suppl 1, pp. S119-26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Blood Pressure*
Hypertension/*chemically induced
Hypertension/*metabolism
Sodium/*metabolism
Sodium Chloride, Dietary/*adverse effects
Aldosterone/metabolism ; Humans ; Kidney/metabolism ; Protein-Serine-Threonine Kinases/metabolism ; Receptors, Mineralocorticoid/metabolism ; Signal Transduction ; Sodium/urine ; Sodium Chloride, Dietary/metabolism ; rac1 GTP-Binding Protein/metabolism
Czasopismo naukowe
Tytuł :
Reactive oxygen species and the central nervous system in salt-sensitive hypertension: possible relationship with obesity-induced hypertension.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan. />Fujita M
Pokaż więcej
Źródło :
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2012 Jan; Vol. 39 (1), pp. 111-6.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Central Nervous System/*metabolism
Hypertension/*etiology
Kidney/*innervation
Obesity/*physiopathology
Reactive Oxygen Species/*metabolism
Sodium Chloride, Dietary/*adverse effects
Sympathetic Nervous System/*metabolism
Adrenergic Fibers/metabolism ; Animals ; Brain/metabolism ; Central Nervous System/physiopathology ; Humans ; Hypertension/metabolism ; Hypertension/physiopathology ; Kidney/metabolism ; Kidney/physiopathology ; Sympathetic Nervous System/physiopathology ; Synaptic Transmission
Czasopismo naukowe
Tytuł :
Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Haneda M
Ito S
Kashihara N
Node K
Nangaku M
Shimosawa T
Kishimoto J
Fujita T
Pokaż więcej
Źródło :
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2011 Aug; Vol. 25 (4), pp. 341-7.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Albuminuria/*drug therapy
Amlodipine/*administration & dosage
Azetidinecarboxylic Acid/*analogs & derivatives
Calcium Channel Blockers/*administration & dosage
Diabetic Nephropathies/*drug therapy
Dihydropyridines/*administration & dosage
Hypertension/*drug therapy
Imidazoles/*administration & dosage
Sympatholytics/*administration & dosage
Tetrazoles/*administration & dosage
Adult ; Aged ; Azetidinecarboxylic Acid/administration & dosage ; Drug Therapy, Combination ; Humans ; Middle Aged ; Research Design
Czasopismo naukowe
Tytuł :
Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Autorzy :
Kawarazaki H; Department of Nephrology and Endocrinology, University of Tokyo, Tokyo, Japan. />Ando K
Fujita M
Matsui H
Nagae A
Muraoka K
Kawarasaki C
Fujita T
Pokaż więcej
Źródło :
American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2011 Jun; Vol. 300 (6), pp. F1402-9. Date of Electronic Publication: 2011 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Kidney Injury/*metabolism
Hypertension/*metabolism
Kidney/*metabolism
Receptors, Mineralocorticoid/*metabolism
Sodium Chloride/*administration & dosage
Acute Kidney Injury/chemically induced ; Aldosterone/blood ; Analysis of Variance ; Angiotensin II Type 1 Receptor Blockers/pharmacology ; Animals ; Blood Pressure/drug effects ; Eplerenone ; Hypertension/chemically induced ; Imidazoles/pharmacology ; Immunohistochemistry ; Kidney/drug effects ; Male ; Radioimmunoassay ; Rats ; Rats, Sprague-Dawley ; Reverse Transcriptase Polymerase Chain Reaction ; Spironolactone/analogs & derivatives ; Tetrazoles/pharmacology
Czasopismo naukowe
Tytuł :
Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Autorzy :
Kawarazaki H; Department of Nephrology and Endocrinology, University of Tokyo, School of Medicine, Tokyo, Japan. />Ando K
Nagae A
Fujita M
Matsui H
Fujita T
Pokaż więcej
Źródło :
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2010 Sep; Vol. 25 (9), pp. 2879-89. Date of Electronic Publication: 2010 Apr 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hypertension/*etiology
Kidney/*drug effects
Receptors, Mineralocorticoid/*metabolism
Renal Insufficiency/*etiology
Sodium Chloride, Dietary/*toxicity
8-Hydroxy-2'-Deoxyguanosine ; Animals ; Antihypertensive Agents/pharmacology ; Antioxidants/pharmacology ; Blood Pressure/drug effects ; Cyclic N-Oxides/pharmacology ; Deoxyguanosine/analogs & derivatives ; Deoxyguanosine/metabolism ; Eplerenone ; Hydralazine/pharmacology ; Hypertension/drug therapy ; Hypertension/metabolism ; Kidney/metabolism ; Male ; Mineralocorticoid Receptor Antagonists/pharmacology ; Rats ; Rats, Inbred Dahl ; Renal Insufficiency/drug therapy ; Renal Insufficiency/metabolism ; Spin Labels ; Spironolactone/analogs & derivatives ; Spironolactone/pharmacology
Czasopismo naukowe
Tytuł :
Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, Faculty of Medicine, University of Tokyo Hospital, Tokyo, Japan.
Ohtsu H
Arakawa Y
Kubota K
Yamaguchi T
Nagase M
Yamada A
Fujita T
Pokaż więcej
Corporate Authors :
Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect Study Investigators
Źródło :
Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2010 Jun; Vol. 33 (6), pp. 616-21. Date of Electronic Publication: 2010 Apr 09.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Albuminuria/*drug therapy
Blood Pressure/*drug effects
Hypertension/*drug therapy
Mineralocorticoid Receptor Antagonists/*therapeutic use
Spironolactone/*analogs & derivatives
Adult ; Aged ; Albuminuria/complications ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/therapeutic use ; Chronic Disease ; Creatine/blood ; Drug Therapy, Combination ; Eplerenone ; Female ; Humans ; Hypertension/complications ; Kidney/drug effects ; Kidney/physiopathology ; Kidney Diseases/drug therapy ; Male ; Middle Aged ; Sodium Chloride, Dietary/adverse effects ; Spironolactone/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action.
Autorzy :
Ando K; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, 112-8655, Japan. />Matsui H
Fujita M
Fujita T
Pokaż więcej
Źródło :
Current vascular pharmacology [Curr Vasc Pharmacol] 2010 Jan; Vol. 8 (1), pp. 59-63.
Typ publikacji :
Journal Article
MeSH Terms :
Antioxidants/*therapeutic use
Cardiovascular Diseases/*physiopathology
Cardiovascular Diseases/*prevention & control
Hypertension/*physiopathology
Hypertension/*therapy
Potassium, Dietary/*therapeutic use
Sodium Chloride, Dietary/*adverse effects
Animals ; Cardiovascular Diseases/complications ; Dietary Supplements ; Disease Progression ; Humans ; Hypertension/complications ; Hypertension/metabolism ; Insulin Resistance/physiology ; Oxidative Stress/physiology ; Reactive Oxygen Species/agonists ; Reactive Oxygen Species/antagonists & inhibitors ; Reactive Oxygen Species/metabolism ; Sodium Chloride, Dietary/administration & dosage ; Sodium, Dietary/administration & dosage ; Sodium, Dietary/adverse effects ; Sympathetic Nervous System/physiopathology
Czasopismo naukowe
Tytuł :
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Autorzy :
Ando K; Division of Molecular Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan. />Isshiki M
Takahashi K
Pokaż więcej
Corporate Authors :
ONgoing Evaluation of depressor effect And Safety of combination therapy with Telmisartan and low-dose hydrochlorothiazide (ONEAST) Study Group
Źródło :
Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2009 Sep; Vol. 32 (9), pp. 748-52. Date of Electronic Publication: 2009 Jul 10.
Typ publikacji :
Journal Article
MeSH Terms :
Amlodipine/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Antihypertensive Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Benzoates/*therapeutic use
Calcium Channel Blockers/*therapeutic use
Diuretics/*therapeutic use
Hydrochlorothiazide/*therapeutic use
Hypertension/*drug therapy
Aged ; Amlodipine/adverse effects ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Antihypertensive Agents/adverse effects ; Benzimidazoles/adverse effects ; Benzoates/adverse effects ; Blood Pressure/drug effects ; Body Mass Index ; Calcium Channel Blockers/adverse effects ; Diuretics/adverse effects ; Drug Therapy, Combination ; Female ; Heart Rate/drug effects ; Humans ; Hydrochlorothiazide/adverse effects ; Male ; Middle Aged ; Telmisartan ; Treatment Outcome ; Uric Acid/blood
Czasopismo naukowe
Tytuł :
Effect of high fat loading in Dahl salt-sensitive rats.
Autorzy :
Nagae A; Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Fujita M
Kawarazaki H
Matsui H
Ando K
Fujita T
Pokaż więcej
Źródło :
Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2009 Jul; Vol. 31 (5), pp. 451-61.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Pressure/*drug effects
Dietary Fats/*pharmacology
Hypertension/*physiopathology
Kidney/*drug effects
Obesity/*physiopathology
Animals ; Blood Glucose/metabolism ; Blood Pressure/physiology ; Catecholamines/urine ; Disease Models, Animal ; Disease Progression ; Hypertension/etiology ; Insulin/blood ; Intra-Abdominal Fat/drug effects ; Intra-Abdominal Fat/physiopathology ; Kidney/physiopathology ; Male ; Obesity/complications ; Rats ; Rats, Inbred Dahl ; Sodium Chloride, Dietary/pharmacology ; Weight Gain/drug effects ; Weight Gain/physiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies